Cargando…

ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer

Preventive therapy can target hormone-responsive breast cancer (BC) by treatment with selective estrogen receptor modulators (SERMs) and reduce the incidence of BC. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) with relevant predictive values, SNPs in the ZNF...

Descripción completa

Detalles Bibliográficos
Autores principales: Bond, Heather M., Scicchitano, Stefania, Chiarella, Emanuela, Amodio, Nicola, Lucchino, Valeria, Aloisio, Annamaria, Montalcini, Ylenia, Mesuraca, Maria, Morrone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968090/
https://www.ncbi.nlm.nih.gov/pubmed/29867779
http://dx.doi.org/10.3389/fendo.2018.00255

Ejemplares similares